Ishita Drugs and Industries Limited (BOM:524400)

Market Cap	206.51M
Revenue (ttm)	171.64M
Net Income (ttm)	9.71M
Shares Out	2.99M
EPS (ttm)	3.25
PE Ratio	21.24
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,650
Average Volume	2,025
Open	74.87
Previous Close	73.15
Day's Range	66.00 - 74.87
52-Week Range	62.35 - 92.80
Beta	-0.50
RSI	38.93
Earnings Date	Feb 12, 2026

About BOM:524400

Ishita Drugs and Industries Limited manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. The company offers APIs, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics, iodides and citrates, food additives/excipients, and others. It also provides contract manufacturing services for various drug intermediates, fine chemicals, or specialty chemicals. Ishita Drugs and Industries Limited was incorporated in 1992 and is based in A...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1992
• Employees: 14
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524400

Financial Performance

In 2024, BOM:524400's revenue was 149.97 million, a decrease of -1.25% compared to the previous year's 151.88 million. Earnings were 8.68 million, an increase of 15.98%.